These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27481518)

  • 21. Patterns of copy number alterations in primary breast tumors of South African patients and their impact on functional cellular pathways.
    Lupicki K; Elifio-Esposito S; Fonseca AS; Weber SH; Sugita B; Langa BC; Pereira SRF; Govender D; Panieri E; Hiss DC; Abdul-Rasool S; Cavalli LR
    Int J Oncol; 2018 Dec; 53(6):2745-2757. PubMed ID: 30320392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
    Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
    Elife; 2020 Jan; 9():. PubMed ID: 31939734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients.
    Sung JS; Park KH; Kim YH
    Cancer Genet Cytogenet; 2010 Apr; 198(1):27-34. PubMed ID: 20303011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients.
    Wallander K; Eisfeldt J; Lindblad M; Nilsson D; Billiau K; Foroughi H; Nordenskjöld M; Liedén A; Tham E
    PLoS One; 2021; 16(2):e0245488. PubMed ID: 33539436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
    Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
    Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
    Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High tumor mast cell density is associated with longer survival of colon cancer patients.
    Mehdawi L; Osman J; Topi G; Sjölander A
    Acta Oncol; 2016 Dec; 55(12):1434-1442. PubMed ID: 27355473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence.
    Fiedler D; Heselmeyer-Haddad K; Hirsch D; Hernandez LS; Torres I; Wangsa D; Hu Y; Zapata L; Rueschoff J; Belle S; Ried T; Gaiser T
    Int J Cancer; 2019 Apr; 144(7):1561-1573. PubMed ID: 30229897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.
    Roode SC; Rotroff D; Avery AC; Suter SE; Bienzle D; Schiffman JD; Motsinger-Reif A; Breen M
    Chromosome Res; 2015 Dec; 23(4):681-708. PubMed ID: 26037708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors.
    Terashima K; Yu A; Chow WY; Hsu WC; Chen P; Wong S; Hung YS; Suzuki T; Nishikawa R; Matsutani M; Nakamura H; Ng HK; Allen JC; Aldape KD; Su JM; Adesina AM; Leung HC; Man TK; Lau CC
    Pediatr Blood Cancer; 2014 Apr; 61(4):593-600. PubMed ID: 24249158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of chromosome 4q predicts outcome in stage II colon cancer patients.
    Brosens RP; Belt EJ; Haan JC; Buffart TE; Carvalho B; Grabsch H; Quirke P; Cuesta MA; Engel AF; Ylstra B; Meijer GA
    Anal Cell Pathol (Amst); 2010; 33(2):95-104. PubMed ID: 20966546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
    Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
    Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel reference genes in colorectal cancer identify a distinct subset of high stage tumors and their associated histologically normal colonic tissues.
    Xu L; Luo H; Wang R; Wu WW; Phue JN; Shen RF; Juhl H; Wu L; Alterovitz WL; Simonyan V; Pelosof L; Rosenberg AS
    BMC Med Genet; 2019 Aug; 20(1):138. PubMed ID: 31409279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs.
    Castagnola P; Zoppoli G; Gandolfo S; Monticone M; Malacarne D; Cirmena G; Brown D; Aiello C; Maffei M; Marino R; Giaretti W; Pentenero M
    PLoS One; 2015; 10(11):e0142294. PubMed ID: 26540282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
    Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics.
    Tan DS; Camilleri-Broët S; Tan EH; Alifano M; Lim WT; Bobbio A; Zhang S; Ng QS; Ang MK; Iyer NG; Takano A; Lim KH; Régnard JF; Tan P; Broët P
    Int J Cancer; 2014 Sep; 135(5):1092-100. PubMed ID: 24482041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicopathologic significance of chromosomal DNA sequence copy number aberrations in patients with colorectal carcinoma].
    Liu XP; Kawauchi S; Oga A; Sasaki K
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):355-9. PubMed ID: 17892131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of chromosome 4q predicts outcome in stage II colon cancer patients.
    Brosens RP; Belt EJ; Haan JC; Buffart TE; Carvalho B; Grabsch H; Quirke P; Cuesta MA; Engel AF; Ylstra B; Meijer GA
    Cell Oncol (Dordr); 2011 Jun; 34(3):215-23. PubMed ID: 21717218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.